Everything below concerns MC4 receptor. We keep the language plain, cite what the science says, and separate well-supported claims from open questions.
Last reviewed on 2025-10-21. Where a claim depends on a specific study, the study is described rather than over-claimed.
Published research covers ischemic stroke, traumatic brain injury, cognitive impairment, optic nerve conditions and attention-related measures. Much of the human evidence comes from small trials conducted in one country, which limits how far the results generalize. Animal models supply the larger share of the data, and effects seen in rodents do not transfer automatically to people. Reviews have noted that methodological reporting is often incomplete, making it difficult to pool results or compare treatment schedules across studies.
Pharmacokinetic accounts emphasize rapid breakdown. After intravenous dosing the intact peptide disappears from blood within minutes, and nasal delivery produces low but measurable concentrations. Metabolites rather than the parent molecule may account for part of the observed activity, although the relative contribution is unresolved. Dosing in the literature varies widely and no optimal schedule has been agreed. These gaps are regularly cited as a reason the findings have not produced broad clinical adoption beyond the original research setting.
Circulation time for the peptide is short because peptidases cleave it readily. The Pro-Gly-Pro tail is thought to slow breakdown compared with the bare ACTH fragment, but the gain appears modest. Absorption after intranasal dosing is limited, and only a fraction of a dose is expected to reach the central nervous system. Laboratory concentrations therefore sit well above levels achieved systemically, a gap that complicates translation from bench findings to clinical claims.
The mechanisms attributed to semax are inferred from animal and cell studies rather than traced to one confirmed target. The most frequently cited pathway involves increased expression of brain-derived neurotrophic factor and nerve growth factor in hippocampal and cortical tissue. Some work points to engagement of melanocortin receptors, particularly MC4, which the parent ACTH fragment can activate. Effects on dopaminergic and serotonergic signalling have also been reported. No single account explains all observed results, and the relative weight of each pathway remains unsettled.
Published studies examine a fairly narrow set of endpoints. Rodent experiments commonly measure maze learning, infarct volume after induced ischemia, and tissue levels of neurotrophic factors. Clinical reports from Russian centres describe attention, memory and recovery scores in patients after stroke or transient ischemic attack. Most of those human studies are small and few have been repeated by independent groups. Outcome measures differ between studies, which limits direct comparison.
| Property | Value | Notes |
|---|---|---|
| Primary research models | Rodent studies | Largest share of published data |
| Reported markers | BDNF and NGF expression | Measured mainly in animal tissue |
| Common administration | Intranasal | Matches the registered formulation |
| Blood residence time | Minutes | Rapid enzymatic degradation |
| Evidence quality | Small trials, limited replication | Noted repeatedly in reviews |
Claims about enhanced focus, memory, or mood in healthy people rest mostly on anecdotal reports and community discussion rather than on controlled data. It remains unclear whether any cognitive benefit observed in patients recovering from brain injury would extend to uninjured users. Dose-response relationships, long-term safety, and interactions with other drugs are not well characterized in the peer-reviewed literature. Questions about optimal route of administration and treatment duration likewise remain open.
Semax binds to melanocortin receptors and is thought to influence neuronal survival and plasticity rather than to act through the adrenal axis. Laboratory work has shown increased expression of brain-derived neurotrophic factor and nerve growth factor in treated tissue. Changes in c-Fos, a marker of neuronal activation, have also been reported. Because the peptide is rapidly degraded by peptidases, its effects are generally attributed to downstream signaling cascades rather than to sustained receptor occupancy.
Grifols, S.A. (Catalan: [ˈɡɾifuls]) is a global healthcare company and leading producer of plasma-derived medicines founded in Barcelona, Catalonia, Spain, in 1909. With a workforce of over 23,800 employees, Grifols serves more than 110 countries and regions and maintains a direct presence in over 30. Principally a producer of blood plasma–based products and other biopharmaceuticals, the company also operates in transfusion medicine, supplying devices, instruments and reagents for clinical testing laboratories, as well as clinical diagnostic technologies. Furthermore, it provides biological supplies for life-science research, clinical trials and the manufacturing of pharmaceutical and diagnostic products. It has a portfolio on four therapeutic areas: immunology, infectious diseases, pulmonology and critical care.
DSMB. An impartial group that oversees a clinical trial and reviews the results to see if they are acceptable. This group determines if the trial should be changed or closed. Also called DSMB. (NCI) An independent committee, composed of community representatives and clinical research experts, that reviews data while a clinical trial is in progress to ensure that participants are not exposed to undue risk. A DSMB may recommend that a trial be stopped if there are safety concerns or if the trial objectives have been achieved. (NLM) An independent data monitoring committee that may be established by the sponsor to assess at intervals the progress of a clinical trial, the safety data, and the critical efficacy endpoints, and to recommend to the sponsor whether to continue, modify, or stop a trial. (ICH E6 and ICH E9) Diagnostic trials
=== Iraq === In a March 2000 article in The Guardian, Galloway described himself as a supporter of the Iraqi people and the Ba'ath Party, but not Saddam Hussein himself. In a House of Commons debate on 6 March 2002, Foreign Office minister Ben Bradshaw said Galloway was "not just an apologist, but a mouthpiece, for the Iraqi regime over many years." Galloway called the minister a liar and refused to withdraw on the grounds that Bradshaw's claim was "a clear imputation of dishonour", and the sitting was suspended due to the dispute. Bradshaw later withdrew his allegation, and Galloway apologised for using unparliamentary language. Giving evidence in his libel case against The Daily Telegraph in 2004, Galloway testified that he regarded Saddam as a "bestial dictator" and would have welcomed his removal from power, but not by means of a military attack on Iraq. Galloway also pointed out that he was a prominent critic of Saddam Hussein's government in the 1980s, as well as of the role of Margaret Thatcher's government in supporting arms sales to Iraq during the Iran–Iraq War.
== Production and distribution == Entire illicit supply chains dedicated to collecting, processing, and reselling gutter oil have been discovered by regulators in China. Multiple low-end restaurants in China have been found to cook with gutter oil. Additionally, in 2012, the Chinese government accused a Chinese pharmaceutical company of using gutter oil as a precursor for the manufacturing of cephalosporin antibiotics. About two to three million tons of cooking oil containing cancerous substances are produced in China each year. In 2010 it was estimated that approximately one tenth of the meals consumed by people in China could contain gutter oil. Collected waste oil is sold to local workshops or small factories for cleaning and packaging. When sold to workshops it is often transported by bicycle mounted collectors; afterwards, the oil is held in 200-liter barrels at the workshops until it is processed. On other occasions the oil goes to industrial cooking oil refineries for further processing before it finally reaches its end purpose. Reprocessing of used cooking oil is often very rudimentary; techniques include filtration, boiling, refining, and the removal of some adulterants. It is then packaged and resold as a cheaper alternative to normal cooking oil. Another version of gutter oil uses discarded animal parts, animal fat and skins, internal organs, and expired or otherwise low-quality meat, which is then cooked in large vats to extract the oil. Some lower-market restaurants have long-term purchase agreements with oil recyclers for selling their used oil.
amplicon Any DNA or RNA sequence or fragment that is the source and/or product of an amplification reaction. The term is most frequently used to describe the numerous copied fragments that are the products of the polymerase chain reaction or ligase chain reaction, though it may also refer to sequences that are amplified naturally within a genome, e.g. by gene duplication.
Sources: en.wikipedia.org
Butyl lithium (n-C4H9Li) Lithium diisopropylamide (LDA) [(CH3)2CH]2NLi Lithium diethylamide (LDEA) (C2H5)2NLi Sodium amide (NaNH2) Sodium hydride (NaH) Lithium bis(trimethylsilyl)amide [(CH3)3Si]2NLi The strongest superbases are synthesised in only gas phase:
Psychedelics occurring in plants, fungi, and animals have been used by indigenous peoples throughout the world for thousands of years. These psychedelics and their sources include psilocybin and psilocin in psilocybin-containing mushrooms (teonanacatl), dimethyltryptamine (DMT) in ayahuasca (a combination typically of Psychotria viridis and Banisteriopsis caapi), bufotenin in Anadenanthera trees, 5-MeO-DMT in the Colorado River Toad, mescaline in peyote (peyotl) and San Pedro cacti, and ergine and isoergine in morning glories (ololiuqui, tlitliltzin) and ergot, among others. The kykeon of the Eleusinian Mysteries in Ancient Greece might have been a psychedelic, for instance ergot or psilocybin-containing mushrooms. The earliest archeological evidence of the use of psychedelic plants and fungi by humans dates back roughly 10,000 years.
Autocrine signaling is a form of signaling in which a cell secretes a hormone or chemical messenger (called the autocrine agent) that binds to autocrine receptors on the same cell, leading to changes in the cells.
Drawing on existing heroin and cannabis smuggling networks, the Guadalajara Cartel, led by Miguel Ángel Félix Gallardo, emerged as intermediaries, transporting Colombian cocaine across the Mexico–United States border. By the mid-1980s, the Guadalajara Cartel had firmly established itself as a reliable transporter, initially paid in cash but shifting by the late 1980s to a payment-in-kind arrangement. While many factors contributed to the escalation of drug trafficking violence, security analysts trace the origins of cartel power to the unraveling of an implicit arrangement between traffickers and then-ruling Institutional Revolutionary Party (PRI), which began to lose its grip on power in the 1980s. The fighting between rival drug cartels began in earnest after the 1989 arrest of Félix Gallardo, with cartel infighting escalating in the 1990s.
=== Return to Greece === After his Berlin, Dresden and New York years, Zervas decided to return to Greece in 1937. He was immediately appointed full Professor of Organic Chemistry and Biochemistry at the Aristotle University of Thessaloniki in recognition of his distinguished international work. He stayed in this position until 1939, when he was invited to the Professorship of Organic Chemistry at the University of Athens and also appointed director of the Laboratory of Organic Chemistry of the same institution. He continued conducting research, despite the severe limitations he often faced from the lack of equipment and funding. Concurrent to research, Zervas taught organic chemistry, oversaw the laboratory and guided many generations of young chemists as doctoral advisor for the 29 years he held the post at the University of Athens. During the Axis occupation of Greece Zervas played an active part in the Greek Resistance as a member of EDES; he was imprisoned twice, first by the Italian and then by the German occupying forces, and his laboratory was destroyed. Following the liberation of Greece, Zervas managed to secure a small part of the American postwar aid for repairs in the University of Athens and the Athens Polytechnic, and thus rebuilt his laboratory in 1948–1951. In the following years, guided by a sense of personal and professional duty, Zervas voluntarily took on a variety of responsibilities within the Greek state. At his own insistence, he never got paid for these posts and kept receiving only his professorial salary.
Sources: en.wikipedia.org
== Genetics == In terms of the genetics of UCMD1, there are mutations in the genes COL6A1, COL6A2, and COL6A3. This sub-type of muscular dystrophy is both autosomal recessive and autosomal dominant in nature. COL6A1 plays an important part in maintaining the human body's integrity of various tissues. Alpha 1 subunit of type VI collagen is the encoded protein. In terms of the genetics of UCMD2, there are mutations in the gene COL12A1, and is autosomal recessive. Collagen VI is a principal structural component of the extracellular matrix (ECM), where it self-assembles into a distinct microfibrillar network that links the muscle fiber's basal lamina to the surrounding interstitial matrix, thereby anchoring muscle cells to the ECM. Mutations in COL6A1, COL6A2, and COL6A3 impair the proper assembly, secretion, or incorporation of collagen VI microfibrils into the ECM, disrupting its structural integrity and contributing to the muscle-fiber degeneration observed in UCMD.
== Cause == Causes may include trauma or repetitive activities. Less common causes include infection, arthritis, gout, thyroid disease, and diabetes. Obesity, or more specifically, adiposity or fatness, is linked to increasing incidence of tendinopathy. Quinolone antibiotics are associated with increased risk of tendinitis and tendon rupture. A 2013 review found the incidence of tendon injury among those taking fluoroquinolones to be between 0.08 and 0.2%. Fluoroquinolones most frequently affect large load-bearing tendons in the lower limb, especially the Achilles tendon.
== Adverse effects == Common side effects include headache, dizziness, feeling tired, cough, nausea, and rash. Serious side effects may include low blood pressure, liver problems, hyperkalemia, and angioedema. Use is not recommended during the entire duration of pregnancy as it may harm the baby.
It is a once-weekly, two-dose antibiotic, the rights to which Actavis acquired when it bought Durata Therapeutics in 2014. The U.S. Food and Drug Administration (FDA) approved dalbavancin in May 2014, for the treatment of acute bacterial skin and skin structure infections (ABSSSIs) caused by certain susceptible bacteria such as Staphylococcus aureus including methicillin-susceptible and methicillin-resistant strains of Streptococcus pyogenes, in intravenous dosage form.
The word pharmacy is derived from Old French farmacie "substance, such as a food or in the form of a medicine which has a laxative effect" from Medieval Latin pharmacia from Greek pharmakeia (Ancient Greek: φαρμακεία) "a medicine", which itself derives from pharmakon (φάρμακον), meaning "drug, poison, spell" (which is etymologically related to pharmakos).
Sources: en.wikipedia.org
The main proposal is modulation of neurotrophic factors such as brain-derived neurotrophic factor, supported largely by animal experiments. Receptor-level targets have not been firmly established. Most reviews describe the mechanism as only partially characterized.
The compound is registered as a medicine in Russia, so clinical work has concentrated there. Trials elsewhere are few and generally small. This geographic concentration is a recognized limitation in evidence reviews.
Some fraction may reach the central nervous system through olfactory pathways, and this is often cited as the rationale for the nasal route. The size of that fraction in humans is not well quantified. Blood concentrations after nasal dosing are low, which complicates measurement.
It consists mainly of animal experiments and small clinical reports, with much of the clinical material published in Russian-language journals. Large independent trials are scarce. Separating reliable effects from chance findings is consequently difficult.